Circulation Research, Vol 64, 179-192, Copyright © 1989 by American Heart Association

ARTICLES

Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo

K Schulze, BF Becker and HP Schultheiss
Department of Internal Medicine, Klinikum Grosshadern, Munich, Federal Republic of Germany.

We identified the ADP/ATP carrier, located within the inner mitochondrial membrane, to be an organ- and conformation-specific autoantigen in myocarditis and dilated cardiomyopathy. We also showed that autoantibodies to the ADP/ATP carrier inhibit the nucleotide transport in vitro. Specific binding of the autoantibodies to the carrier was demonstrated by radioimmunoassay and the immunoblot technique; the inhibition of the nucleotide transport was determined by the inhibitor stop method. To establish if these autoantibodies might also affect cardiac energy metabolism in vivo, we measured whether they are capable of penetrating into myocytes and whether subcellular ATP/ADP ratios and phosphorylation potentials of ATP change in hearts of guinea pigs that have been immunized with the isolated ADP/ATP carrier. An intracellular deposition of autoantibodies was observed by direct immunofluorescence and by immunoperoxidase staining on cryosections of the myocardial tissue of animals immunized with the ADP/ATP carrier. Furthermore, binding of autoantibodies to mitochondrial membrane structures was shown by immunoelectron- microscopic methods. The cytosolic and intramitochondrial distribution of adenine nucleotides in stimulated, isolated perfused hearts of guinea pigs immunized with the ADP/ATP carrier was measured by nonaqueous fractionation. Compared with controls performing equal external heart work, the cytosolic ATP decreased in the immunized animals, whereas the mitochondrial ATP increased strongly; ADP concentrations showed an opposite change. Thus, a resultant cytosolic decrease and a marked mitochondrial increase of the ATP/ADP ratio was established. As a consequence, the cytosolic-mitochondrial phosphorylation potential of ATP was diminished. These findings demonstrate that antibodies against intracellular antigens are able to penetrate into living cells, and that autoimmunity to the ADP/ATP carrier may contribute to the pathophysiology of myocarditis and dilated cardiomyopathy by causing an autoantibody-mediated imbalance between intracellular energy delivery and demand.

This article has been cited by other articles:

				R. Dennert, H. J. Crijns, and S. Heymans Acute viral myocarditis Eur. Heart J., September 1, 2008; 29(17): 2073 - 2082. [Abstract] [Full Text] [PDF]

				Y. Li, J. S. Heuser, L. C. Cunningham, S. D. Kosanke, and M. W. Cunningham Mimicry and Antibody-Mediated Cell Signaling in Autoimmune Myocarditis J. Immunol., December 1, 2006; 177(11): 8234 - 8240. [Abstract] [Full Text] [PDF]

				A. Dorner, S. Giessen, R. Gaub, H. G. Siestrup, P. L. Schwimmbeck, R. Hetzer, W. Poller, and H.-P. Schultheiss An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy Eur J Heart Fail, January 1, 2006; 8(1): 81 - 89. [Abstract] [Full Text] [PDF]

				P. Liu, P. Lee, K. Fuse, and M. Nian Molecular pathophysiological mechanisms in virus infected host myocardium Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I37 - I41. [Abstract] [PDF]

				P. P. Liu and J. W. Mason Advances in the Understanding of Myocarditis Circulation, August 28, 2001; 104(9): 1076 - 1082. [Full Text] [PDF]

				D. L. Mann Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials? J. Am. Coll. Cardiol., July 1, 2001; 38(1): 184 - 186. [Full Text] [PDF]

				D Alarco Antinuclear antibodies: to penetrate or not to penetrate, that was the question Lupus, May 1, 2001; 10(5): 315 - 318. [PDF]

				H. Nishimura, T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, et al. Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice Science, January 12, 2001; 291(5502): 319 - 322. [Abstract] [Full Text]

				B. Lauer, M. Schannwell, U. Kuhl, B.-E. Strauer, and H.-P. Schultheiss Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis J. Am. Coll. Cardiol., January 1, 2000; 35(1): 11 - 18. [Abstract] [Full Text] [PDF]

				K. Schulze, B. Witzenbichler, C. Christmann, and H.-P. Schultheiss Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator Cardiovasc Res, October 1, 1999; 44(1): 91 - 100. [Abstract] [Full Text] [PDF]

				U. Kuhl, B. Lauer, M. Souvatzoglu, H. Vosberg, and H.-P. Schultheiss Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis--evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1371 - 1376. [Abstract] [Full Text] [PDF]

				A. Maisel, D. Cesario, S. Baird, J. Rehman, P. Haghighi, and S. Carter Experimental Autoimmune Myocarditis Produced by Adoptive Transfer of Splenocytes After Myocardial Infarction Circ. Res., March 9, 1998; 82(4): 458 - 463. [Abstract] [Full Text] [PDF]

				H. Nakamura, T. Yamamura, S. Umemoto, S. Fukuta, T. Shioi, A. Matsumori, S. Sasayama, and M. Matsuzaki Autoimmune Response in Chronic Ongoing Myocarditis Demonstrated by Heterotopic Cardiac Transplantation in Mice Circulation, December 15, 1996; 94(12): 3348 - 3354. [Abstract] [Full Text]

				H.-P. Schultheiß, K. Schulze, R. Schauer, B. Witzenbichler, and B. E. Strauer Antibody-Mediated Imbalance of Myocardial Energy Metabolism : A Causal Factor of Cardiac Failure? Circ. Res., January 1, 1995; 76(1): 64 - 72. [Abstract] [Full Text]